ArticleBMC veterinary research2025
Histopathologic evaluation of skin wound healing due to local application of transdermal chitosan patch in combination with doxycycline, zinc nanoparticles, and selenium nanoparticles in mice.
Article in BMC veterinary research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Biological Models for Evaluating Hydrogel-Based Formulations in Wound Healing.Gels (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe aim of this study is to compare the histopathological changes in experimental skin wound healing in mice treated with a topical application of chitosan combined with doxycycline, as well as zinc and selenium nanoparticles.
methodsFifty mice with experimental skin wounds were divided into four equal groups: a control group with no therapeutic intervention, a CsD group receiving a transdermal patch containing doxycycline, a CsDZn group receiving a transdermal patch with chitosan-doxycycline-zinc nanoparticles, a CsZnS group receiving a transdermal patch with chitosan-zinc and selenium nanoparticles, and a CsDZnS group receiving a transdermal patch containing chitosan-doxycycline-zinc and selenium nanoparticles. After synthesizing and confirming the efficacy of the transdermal patches, we measured the wound area and histological indices of wound healing on the 7th and 14th days of the study.
resultsThe results showed that the use of selenium and zinc nanoparticles leads to a decrease in the wound surface in the CsDZnS group compared to the control group and remaining experimental groups. A significant reduction in inflammation and hemorrhage was recorded in the CsDZnS group compared to other groups. On the seventh day of the study, angiogenesis in the CsDZnS group was higher than in the other groups. In addition, on the 14th day of the study, orientation of collagen fibers and re-epithelialization were more observed in the CsDZnS group compared to the other groups.
conclusionThe chitosan skin patch containing doxycycline, zinc nanoparticles, and selenium nanoparticles (CsDZnS group) demonstrated the most effective results in skin healing, as evidenced by the highest control of inflammation on days 7 and 14, the greatest re-epithelialization on day 14, and the smallest wound area on both days compared to the other evaluated groups.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.